InvestorsHub Logo
Followers 32
Posts 4233
Boards Moderated 0
Alias Born 07/25/2007

Re: DewDiligence post# 2101

Tuesday, 11/23/2021 3:56:04 PM

Tuesday, November 23, 2021 3:56:04 PM

Post# of 3181

Update on ENTA’s HBV development plan:

Based on yesterday’s CC, ENTA will not advance the EDP-514/nuc 2-drug combination into phase-2, but rather will look to find a suitable third agent before proceeding.



Thanks Dew. I haven't had a chance to listen to or read the CC. Any word on how long of a time frame they estimate that it will be until their third agent could enter safety trials?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News